Blood cancer Clinical Trials in Ann Arbor, MI
As of August 2026, 41 paid clinical trials are recruiting for Blood cancer in Ann Arbor, Michigan. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Ann Arbor
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
43 clinical trials for Blood cancer
·Clear filters·A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Quantitative MRI for Myelofibrosis
Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Living Well With Lymphoma
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Top Research Study Locations in Ann Arbor
Researchers run research studies in Ann Arbor, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Michigan | Healthy, Heart Failure, Acute Kidney Injury | 389 |
| University of Michigan Rogel Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | 80 |
| Trinity Health Saint Joseph Mercy Hospital Ann Arbor | Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Acute Myeloid Leukemia | 65 |
| C S Mott Children's Hospital | B Acute Lymphoblastic Leukemia, Neuroblastoma, Acute Myeloid Leukemia | 29 |
| University of Michigan Comprehensive Cancer Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Carcinoma | 27 |
| University of Michigan Health System | Chronic Kidney Disease, ADA SCID, Adolescent Congenital Heart Disease | 23 |
| VA Ann Arbor Healthcare System, Ann Arbor, MI | Prostate Cancer, Adult Growth Hormone Deficiency, Alcohol Use Disorder | 23 |
| C.S. Mott Children's Hospital | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Anaplastic Astrocytoma | 18 |
| University of Michigan Hospital | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 14 |
| University of Michigan School of Dentistry | Gum Disease, Healing Wound, Dental Diseases | 9 |
| University of Michigan Health | Aortic Stenosis, Breast Reconstruction, Colorectal Adenoma | 8 |
| University of Michigan Hospitals | Propionic Acidemia, Adenoid Cystic Carcinoma, Chromophobe Renal Cell Carcinoma | 8 |
| University of Michigan Medical Center | Liver Transplant, Cutaneous Melanoma, Stage II, Glomerulosclerosis, Focal Segmental | 8 |
| Michigan Medicine | Sleep Apnea, Obstructive, Aging, Alzheimer Disease | 6 |
| University of Michigan Kellogg Eye Center | Cone Rod Dystrophy, Juvenile Macular Degeneration, Stargardt Disease | 6 |
| University of Michigan, Michigan Medicine | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 6 |
| CS Mott Children's Hospital | Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Advanced Solid Tumor | 5 |
| Trinity Health IHA - Obstetrics and Gynecology West Arbor | Ampulla of Vater Carcinoma, Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 5 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Multiple Myeloma, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis | 4 |
| Saint Joseph Mercy Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Castration Levels of Testosterone | 4 |
| The University of Michigan | Down Syndrome, Hypertonia, Muscle, Nasal Airway Obstruction | 4 |
| VA Ann Arbor Healthcare System | Cardiovascular Diseases, Castrate-sensitive, Castrate-sensitive Prostate Cancer | 4 |
| University of Michigan Health System - Ann Arbor | Asthma, Plasma Cell Myeloma Refractory, Autoimmune Haemolytic Anaemia | 4 |
| C.S Mott Children's Hospital | Neuroblastoma | 3 |
| Michigan Med University of Michigan | ANCA Associated Vasculitis (AAV), Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
Active & Upcoming Studies in Ann Arbor (2026)
Recruiting trials in Ann Arbor grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (280 active studies)
- Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome · Phase 1 · University of Michigan Rogel Cancer Center
- Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial · University of Michigan Rogel Cancer Center
Neurology & pain (76 active studies)
- This Study Evaluates the Use of a Data-driven Lower Limb Exoskeleton Controller for Stroke Rehabilitation. · University of Michigan
- Telerehabilitation for Post-Stroke Hand Function · University of Michigan
Cardiovascular (61 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- Mobile Health Intervention to Increase Activity in Heart Failure Study · University of Michigan
Diabetes & metabolic (26 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- Leveraging Interventions for Needs and Knowledge in Diabetes (LINKD) · University of Michigan
Mental health & behavior (23 active studies)
- Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression · University of Michigan
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
Pediatric (15 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Eye & vision (10 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · Astellas Pharma Global Development, Inc.
HIV / STI (5 active studies)
- A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH) · University of Michigan
- National Liver Cancer Screening Trial · Phase 4 · University of Texas Southwestern Medical Center
Vaccines (4 active studies)
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
- KIDney Injury in Times of COVID-19 (KIDCOV) · University of California, San Francisco
Common conditions studied in Ann Arbor
- Heart Failure (10 active studies)
- Malignant Solid Neoplasm (10 active studies)
- Obesity (10 active studies)
- Stroke (10 active studies)
- Advanced Solid Tumor (9 active studies)
- Prostate Cancer (9 active studies)
Leading research sponsors in Ann Arbor
- University of Michigan
- University of Michigan Rogel Cancer Center
- National Cancer Institute (NCI)
- VA Office of Research and Development
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Ann Arbor?
There are approximately 970 recruiting clinical trials in Ann Arbor, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Ann Arbor pay participants?
Most recruiting trials in Ann Arbor compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Ann Arbor?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Ann Arbor?
The most common conditions under active study in Ann Arbor include Heart Failure (10), Malignant Solid Neoplasm (10), Obesity (10), Stroke (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Ann Arbor?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Ann Arbor on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Ann Arbor?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Ann Arbor?
Recruiting research sites in Ann Arbor include University of Michigan, University of Michigan Rogel Cancer Center, Trinity Health Saint Joseph Mercy Hospital Ann Arbor, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Ann Arbor right now?
The largest active categories in Ann Arbor are Cancer & tumors (280), Neurology & pain (76), Cardiovascular (61). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.